Welcome to Mesothelioma.net - Turning Hope and Faith into Action.

Worldwide Mesothelioma Incidence Expected to Rise

A recent report tracking trends in medical research and drug development has forecast that the worldwide incidence of malignant mesothelioma is expected to rise in the next several years. It also details the continuing efforts into finding a cure for this rare and fatal form of cancer.

Among the key takeaways for healthcare professionals, mesothelioma patients, and those in the scientific and mesothelioma advocacy communities are the following:

  • The number of mesothelioma deaths that were reported worldwide among adults aged 45 or older was 18,370 in 2016. That number does not include those whose asbestos-related disease were not specifically diagnosed.
  • It is anticipated that by the year 2025, the number of mesothelioma deaths worldwide among the 45 or older population will surpass 22,000.
  • The area of the world that is currently hardest hit by malignant mesothelioma is Oceania, which has a disease incidence of 2.85 per 100,000 males and 0.50 per 100,000 females. Countries in the Caribbean and in Latin America have the lowest incidence of the disease.
  • Pemetrexed (Alimta) continues to be the only drug that has been approved for the treatment of malignant mesothelioma in the United States by the Food and Drug Administration. Other drugs are in various stages of development and clinical testing, with most of the industry-sponsored drugs currently in Phase II testing. The drug that is closest to coming to market is a liquid formulation of pemetrexed.
  • Though the United States is forecast to have far fewer patients diagnosed with malignant mesothelioma than either European countries or Asian countries, it has far more clinical trials for mesothelioma drugs that are ongoing. Following the United States is the United Kingdom for Europe, and Japan for Asia. Japan also has the highest incidence of mesothelioma. Worldwide, most of the drugs under development are in early and mid-phases.

If you have been diagnosed with malignant mesothelioma and need information on access to clinical trials, support groups, care providers or any other resources, contact the Patient Advocates at Mesothelioma.net. We can be reached at 1-800-692-8608.

Terri Oppenheimer

Terri Oppenheimer is an independent writer, editor and proofreader. She graduated from the College of William and Mary with a degree in English. Her dreams of a writing career were diverted by a need to pay her bills. She spent a few years providing copy for a major retailer, then landed a lucrative career in advertising sales. With college bills for all three of her kids paid, she left corporate America for a return to her original goal of writing. She specializes in providing content for websites and finds tremendous enjoyment in the things she learns while doing her research. Her specific areas of interest include health and fitness, medical research, and the law.

Get Your FREE Resources Sent Overnight

resources-shot_optimized
  • New treatment options
  • Veterans benefits & claims
  • $30 Billion asbestos trust fund information
– Or Call – 1-800-692-8608

Site Navigation

Where can I

Get Additional Help?

For over 15 years, we’ve provided the best FREE resources to mesothelioma patients and loved ones. Our resources include information on the leading treatment options and best doctors in your area; lessons learned from survivors; claims and benefits specifically for Veterans; and how to access your share of billions of dollars in trust fund money.

Get Your FREE Resources Sent Overnight

resources-shot_optimized
  • New Treatment Options
  • Veteran's Benefits & Claims
  • $30 Billion Asbestos Trust Fund Information
– Or Call – 1-800-692-8608

We are here to help you

support_staff

If you've been diagnosed with asbestos-related cancer, contact us at 1-800-692-8608 to find out if you are eligible to receive compensation. You can also fill out the form above to receive FREE information.